Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Dietary Adjustments Following GLP-1 Agonist Treatment: The GLaD Feasibility Study

NCT07001553 is registered in ClinicalTrials.gov with Australian Catholic University as lead sponsor.

NCT NCT07001553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07001553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Dietary Adjustments Following GLP-1 Agonist Treatment: The GLaD Feasibility Study
Lead sponsor
Australian Catholic University
Phase
Observational
Overall status
Completed
Start date
May 28, 2025
Completion date
January 7, 2026
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type 2 diabetes mellitus (t2dm)